It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1995.
1995 | Mumbai, Maharashtra, India | ActiveRiddhi Pharmaceuticals Limited, a active public limited company, was established on 24 November 1995 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24230MH1995PLC094749. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.20 Cr and a paid-up capital of ₹0.93 M.
It upholds a compliant status. Its leadership includes Rahul Ashokkumar Jain (Director), Abhay Uttamchand Jain (Director), Pravin Keshrimal Jain (Director). Past directors included Jitendra Labhshankar Dadia, Kalpesh Surendra Dadia, Rahul Ashokkumar Jain. Its latest AGM occurred on 29 August 2025, with the balance sheet filed on 31 March 2025. It is based at Gala No. 127, Damji Shamji Industrial Complex, Mahakali Caves Road, Andheri East, Mumbai, Maharashtra, 400093.
U24230MH1995PLC094749
094749
24 November 1995
₹1.20 Cr
₹0.93 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Riddhi Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Ashokkumar Jain | Director | 10 Mar 2014 | Current |
| Abhay Uttamchand Jain | Director | 10 Mar 2014 | Current |
| Pravin Keshrimal Jain | Director | 10 Mar 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Mar 2016 | Past |
| Pramod Abcsdd | Director | 10 Mar 2016 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2014 | Past |
| Pramod Abcsdd | Director | 10 Mar 2016 | Past |
| Pramod Abcsdd | Director | 10 Mar 2016 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Riddhi Pharmaceuticals Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 53.73% decrease. The company also saw a substantial fall in profitability, with a 54.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Riddhi Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Riddhi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Riddhi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riddhi Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Riddhi Pharmaceuticals Limited last Annual general meeting of members was held on 29 Aug 2025 as per latest MCA records. was recorded as a recent event.
Progress on Riddhi Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Rahul Ashokkumar Jain was appointed as a Director was appointed as a Director on 10 Mar 2014 & has been associated with this company since 11 years 10 months . was recorded as a recent event.
The activity Abhay Uttamchand Jain was appointed as a Director was appointed as a Director on 10 Mar 2014 & has been associated with this company since 11 years 10 months . was completed.
Pravin Keshrimal Jain was appointed as a Director was appointed as a Director on 10 Mar 2014 & has been associated with this company since 11 years 10 months . was recorded as a recent event.
Riddhi Pharmaceuticals Limited was registered on 24 Nov 1995 with Roc Mumbai & aged 30 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Riddhi Pharmaceuticals Limited is U24230MH1995PLC094749.
Riddhi Pharmaceuticals Limited is headquartered at Gala No. 127, Damji Shamji Industrial Complex, Mahakali Caves Road, Andheri East, Mumbai, Maharashtra, 400093.
Riddhi Pharmaceuticals Limited was incorporated on 24 November 1995.
The current directors of Riddhi Pharmaceuticals Limited are
The primary industry of Riddhi Pharmaceuticals Limited is Pharma.
Riddhi Pharmaceuticals Limited is unlisted.
The authorized capital of Riddhi Pharmaceuticals Limited is ₹1.20 Cr, and the paid-up capital is ₹0.93 M.
The compliance status of Riddhi Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX